Clovis Oncology Logo Vector
Clovis Oncology is a pharmaceutical company that develops and commercializes targeted therapies for cancer. The company's lead product, Rubraca, is a PARP inhibitor approved for the treatment of ovarian cancer. Clovis is also developing several other oncology drugs, including rociletinib, a tyrosine kinase inhibitor for the treatment of lung cancer.
